ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0283

The Performance of Rule-Based Algorithms to Identify Patients With Idiopathic Inflammatory Myopathies in Electronic Health Records

Ana Valle1, Amy Vo2, Rochelle Castillo1, Yumeko Kawano3, Leah Santacroce3, Daniel Solomon4, Katherine Liao3 and Candace Feldman3, 1Brigham and Women's Hospital, Brookline, MA, 2Harvard Medical School, Boston, 3Brigham and Women's Hospital, Boston, MA, 4Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Administrative Data, Bioinformatics, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0280–0305) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Idiopathic inflammatory myopathies (IIM; including dermatomyositis, polymyositis, and inclusion body myositis) are heterogenous systemic inflammatory conditions that cause significant disability and morbidity. The study of these rare diseases (prevalence of 10-20/100,000) is limited by our ability to accurately classify cases with a high positive predictive value (PPV). Rule-based algorithms that rely on ICD codes have been used to identify IIM prevalence based on administrative claims and IIM hospitalizations with reported PPVs of 90% or higher. The objective of this study was to apply published rule-based ICD-based algorithms to electronic health record (EHR) data to identify IIM cases to build an IIM cohort.

Methods: Data was extracted from a multihospital EHR system. We identified patients with >1 ICD 9/10 codes for IIM (359.7*, 710.3, 710.4, G72.4*, M33.*, M36.*) between 1/1/2000 – 9/6/2024; from this set, a random sample of 250 patients were selected for chart review. Subjects were classified as having “definite”, “probable”, “possible”, or “unlikely” IIM per the 2017 EULAR/ACR Classification Criteria. ICD codes were extracted for all subjects. The performance of 8 previously published rule-based algorithms for IIM were compared against “definite” cases of IIM from chart review. Algorithms developed using ICD-9 codes were updated to map to ICD-10 codes. Reviews were performed by two independent reviewers (ALV, AV) and discrepancies were adjudicated by a blinded third reviewer (RLC). As the goal was to create an IIM cohort for study, the key performance characteristic of interest was PPV. Specificity, sensitivity, and negative predictive value (NPV) were also calculated.

Results: We identified 5706 patients with >1 IIM ICD 9 or 10 code from the EHR. The prevalence of definite IIM in this cohort was 34.8% (Table 1). M33.* (dermatopolymyositis) was the most common code (35.2%) in the cohort. The highest PPV achieved was 65% with >2 IIM ICD codes in the outpatient setting within 2 months (Algorithm 1) and IIM ICD codes used >2 times between 30 and 365 days (Algorithm 7, Table 2). Algorithm 7 classified 67.8% of definite IIM cases. The algorithm achieving the highest specificity at 94% had low sensitivity (16%) (Algorithm 5, Table 2).

Conclusion: The best performing rule-based IIM algorithms correctly classified 65% of definite IIM cases. The lower performance from prior reports may be due to the different patient populations and lack of direct mapping of ICD-9 codes to ICD-10 codes. Future directions include considering a broader range of EHR data including IIM treatments or data extracted using natural language processing related to IIM characteristics to improve the ability to accurately classify IIM cases at high PPV (≥80%); a crucial first step for IIM studies.

Supporting image 1

Supporting image 2


Disclosures: A. Valle: None; A. Vo: None; R. Castillo: Chronicle Medical Software, Inc., 2; Y. Kawano: None; L. Santacroce: None; D. Solomon: Amgen, 5, CorEvitas, 5, GreenCape Health, 8, Janssen, 5, UpToDate, 9; K. Liao: Merck/MSD, 2, UCB, 2; C. Feldman: American College of Rheumatology, 2, Arthritis Foundation, 5, 12, Task Force Member, Bain Capital, 2, Bristol-Myers Squibb Foundation, 5, Harvard Pilgrim, 2, Lupus Foundation of America, 1, 12, Associate Editor, Medical-Scientific Advisory Board Member, OM1, Inc., 2.

To cite this abstract in AMA style:

Valle A, Vo A, Castillo R, Kawano Y, Santacroce L, Solomon D, Liao K, Feldman C. The Performance of Rule-Based Algorithms to Identify Patients With Idiopathic Inflammatory Myopathies in Electronic Health Records [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-performance-of-rule-based-algorithms-to-identify-patients-with-idiopathic-inflammatory-myopathies-in-electronic-health-records/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-performance-of-rule-based-algorithms-to-identify-patients-with-idiopathic-inflammatory-myopathies-in-electronic-health-records/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology